Zions Bancorporation’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | $1.6M | Buy |
16,060
+3,982
| +33% | +$411K | 0.1% | 177 |
|
|
2024
Q3 | $1.37M | Buy |
12,078
+1,267
| +12% | +$151K | 0.1% | 174 |
|
|
2024
Q2 | $1.34M | Sell |
10,811
-3,593
| -25% | -$463K | 0.11% | 149 |
|
|
2024
Q1 | $1.9M | Sell |
14,404
-1,173
| -8% | -$145K | 0.14% | 125 |
|
|
2023
Q4 | $1.7M | Buy |
15,577
+331
| +2% | +$34.4K | 0.12% | 137 |
|
|
2023
Q3 | $1.57M | Buy |
15,246
+709
| +5% | +$76.4K | 0.14% | 125 |
|
|
2023
Q2 | $1.68M | Buy |
14,537
+313
| +2% | +$35.5K | 0.14% | 112 |
|
|
2023
Q1 | $1.51M | Sell |
14,224
-25,462
| -64% | -$2.75M | 0.13% | 119 |
|
|
2022
Q4 | $4.4M | Sell |
39,686
-17,380
| -30% | -$1.78M | 0.35% | 42 |
|
|
2022
Q3 | $4.91M | Sell |
57,066
-12,225
| -18% | -$1.09M | 0.51% | 25 |
|
|
2022
Q2 | $6.32M | Sell |
69,291
-5,303
| -7% | -$470K | 0.63% | 19 |
|
|
2022
Q1 | $6.12M | Buy |
74,594
+18,014
| +32% | +$1.42M | 0.55% | 16 |
|
|
2021
Q4 | $4.34M | Sell |
56,580
-10,058
| -15% | -$801K | 0.38% | 25 |
|
|
2021
Q3 | $5.01M | Buy |
66,638
+4,100
| +7% | +$312K | 0.51% | 17 |
|
|
2021
Q2 | $4.86M | Buy |
62,538
+23,379
| +60% | +$1.74M | 0.49% | 16 |
|
|
2021
Q1 | $2.88M | Buy |
39,159
+4,786
| +14% | +$353K | 0.33% | 30 |
|
|
2020
Q4 | $2.68M | Buy |
34,373
+8,091
| +31% | +$619K | 0.34% | 28 |
|
|
2020
Q3 | $2.08M | Buy |
26,282
+3,086
| +13% | +$242K | 0.3% | 39 |
|
|
2020
Q2 | $1.71M | Buy |
23,196
+5,950
| +35% | +$448K | 0.25% | 48 |
|
|
2020
Q1 | $1.27M | Buy |
17,246
+10,997
| +176% | +$864K | 0.22% | 50 |
|
|
2019
Q4 | $542K | Sell |
6,249
-694
| -10% | -$57K | 0.08% | 102 |
|
|
2019
Q3 | $558K | Sell |
6,943
-268
| -4% | -$21.5K | 0.08% | 104 |
|
|
2019
Q2 | $577K | Sell |
7,211
-1,557
| -18% | -$119K | 0.08% | 95 |
|
|
2019
Q1 | $696K | Sell |
8,768
-1,491
| -15% | -$112K | 0.11% | 89 |
|
|
2018
Q4 | $748K | Sell |
10,259
-699
| -6% | -$49.3K | 0.55% | 34 |
|
|
2018
Q3 | $741K | Sell |
10,958
-641
| -6% | -$40.8K | 0.18% | 70 |
|
|
2018
Q2 | $671K | Buy |
+11,599
| New | +$654K | 0.46% | 42 |
|
|
2017
Q4 | – | Sell |
-32,877
| Closed | -$2.01M | – | 842 |
|
|
2017
Q3 | $2.01M | Buy |
32,877
+11,105
| +51% | +$673K | 0.29% | 48 |
|
|
2017
Q2 | $1.33M | Sell |
21,772
-1,518
| -7% | -$92.4K | 0.23% | 58 |
|
|
2017
Q1 | $1.41M | Sell |
23,290
-10,459
| -31% | -$635K | 0.27% | 43 |
|
|
2016
Q4 | $1.9M | Sell |
33,749
-926
| -3% | -$54.2K | 0.33% | 41 |
|
|
2016
Q3 | $2.08M | Sell |
34,675
-295
| -0.8% | -$17.3K | 0.39% | 36 |
|
|
2016
Q2 | $1.98M | Buy |
34,970
+215
| +0.6% | +$11.4K | 0.34% | 39 |
|
|
2016
Q1 | $1.84M | Sell |
34,755
-1,090
| -3% | -$53.4K | 0.33% | 41 |
|
|
2015
Q4 | $1.7M | Buy |
35,845
+3,216
| +10% | +$162K | 0.3% | 45 |
|
|
2015
Q3 | $1.69M | Sell |
32,629
-3,124
| -9% | -$166K | 0.31% | 44 |
|
|
2015
Q2 | $1.94M | Buy |
35,753
+2,935
| +9% | +$165K | 0.31% | 47 |
|
|
2015
Q1 | $1.8M | Buy |
+32,818
| New | +$1.86M | 0.31% | 43 |
|
Other funds holding MRK
Zions Bancorporation's MRK Position: Q4 2024 in Review
Zions Bancorporation increased its Merck (MRK) stake by 33% in Q4 2024, buying an estimated $411K and bringing the position to 16,060 shares worth $1.6M. The position accounts for 0.1% of the portfolio, ranked #177.
Zions Bancorporation first reported a position in MRK in Q1 2015 and has held it in 38 quarters since. The position peaked at $6.32M in Q2 2022. 3,608 funds tracked by Wall St. Rank hold MRK as of Q4 2024.
- Zions Bancorporation held 16,060 shares of Merck worth $1.6M as of Q4 2024.
- Zions Bancorporation bought 3,982 Merck shares in Q4 2024, an estimated $411K.
- Merck made up 0.1% of Zions Bancorporation's portfolio in Q4 2024, its #177 holding.
- Zions Bancorporation first reported a position in Merck in Q1 2015 and has held it in 38 quarters since.
- Zions Bancorporation's Merck position peaked at $6.32M in Q2 2022.
- 3,608 funds tracked by Wall St. Rank held Merck as of Q4 2024.
Based on Zions Bancorporation's 13F filing for Q4 2024, filed 11 Feb 2025.